Shares of Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.29 and traded as low as $0.25. Northwest Biotherapeutics shares last traded at $0.26, with a volume of 3,531,938 shares trading hands.
Northwest Biotherapeutics Trading Up 3.3 %
The company has a market cap of $352.47 million, a price-to-earnings ratio of -3.25 and a beta of -0.51. The firm’s fifty day moving average price is $0.27 and its 200-day moving average price is $0.29.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Featured Articles
- Five stocks we like better than Northwest Biotherapeutics
- 3 Fintech Stocks With Good 2021 Prospects
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- High Flyers: 3 Natural Gas Stocks for March 2022
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- What Are Treasury Bonds?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
